Concepedia
Statistics
Publications
6
Citations
560
H-Index
Active since
2008
Affiliations
Pfizer (United States)(Current)
GlaxoSmithKline (United States)
GlaxoSmithKline (United Kingdom)
Jill Skepner is an author at Pfizer (United States) specializing in life sciences, pharmacology, and medicinal chemistry.
Publications per year
2008–2018
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
Sangeeta Goswami, Irina Apostolou, Jan Zhang et al. · Journal of Clinical Investigation · 2018 · 239 citations · Full text
Life Sciences, Immunology, Oncology +17
Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo
Jill Skepner, Radha Ramesh, Mark Trocha et al. · The Journal of Immunology · 2014 · 136 citations
Life Sciences, Immunology, Medicinal Chemistry +17
Discovery and Characterization of QPT-1, the Progenitor of a New Class of Bacterial Topoisomerase Inhibitors
Alita A. Miller, Gordon L. Bundy, John E. Mott et al. · Antimicrobial Agents and Chemotherapy · 2008 · 88 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +15
Discovery of Potent Inhibitors of Soluble Epoxide Hydrolase by Combinatorial Library Design and Structure-Based Virtual Screening
Xing Li, Joseph J. McDonald, Steve A. Kolodziej et al. · Journal of Medicinal Chemistry · 2011 · 56 citations
Pharmacy, Medicinal Chemistry, Pharmacology +14
Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes
Jill Skepner, Lorraine D. Shelly, Chengjie Ji et al. · Prostaglandins & Other Lipid Mediators · 2010 · 22 citations
Life Sciences, Endocrinology, Pharmacology +14
1–5 of 6